Open AccessCatheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation<subtitle>A Systematic Review</subtitle>
Author(s) -
Amit Noheria
Publication year - 2008
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.168.6.581
Subject(s) - medicine , atrial fibrillation , confidence interval , catheter ablation , randomized controlled trial , clinical trial , hazard ratio , clinical endpoint , adverse effect , cardiology
Circumferential pulmonary vein ablation (CPVA) has become common therapy for atrial fibrillation (AF), but results of large randomized controlled trials comparing this procedure with antiarrhythmic drug therapy (ADT) have not been published to date. We conducted a systematic literature review to assess whether CPVA is superior to ADT for the management of AF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom